Moore David Scott bought CRVS
October 2, 2025 · Form 4 insider transaction
Moore David Scott bought 30,000 shares of Corvus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$0.00
Total value
N/A
InsiderMoore David Scott
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 2, 2025
Filing dateOctober 6, 2025
Shares owned after30,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The underlying shares subject to the option vest and become exercisable as to one-third (1/3rd) of the shares subject to the option on each annual anniversary measured from October 2, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.